INmune Bio Inc.
INMB
$2.17
$0.094.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.42M | -41.60M | -45.93M | -49.89M | -55.51M |
| Total Depreciation and Amortization | 202.00K | 136.00K | 84.00K | 28.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | 6.00K | 21.00K |
| Total Other Non-Cash Items | 8.44M | 25.13M | 25.80M | 24.24M | 23.60M |
| Change in Net Operating Assets | -5.19M | -2.82M | -2.53M | -5.04M | -311.00K |
| Cash from Operations | -14.96M | -19.16M | -22.58M | -30.65M | -32.20M |
| Capital Expenditure | -766.00K | -1.04M | -1.04M | -899.00K | -706.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -766.00K | -1.04M | -1.04M | -899.00K | -706.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -2.50M | -5.00M |
| Issuance of Common Stock | 749.00K | 22.27M | 27.55M | 27.97M | 40.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.00K | 67.00K | 67.00K | -- | -- |
| Cash from Financing | 816.00K | 22.34M | 27.61M | 25.47M | 35.26M |
| Foreign Exchange rate Adjustments | -52.00K | -114.00K | -159.00K | 265.00K | -50.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.96M | 2.02M | 3.83M | -5.82M | 2.31M |